Registro:

Referencias:

• De Lustig, E.S., Serra, J.A., Kohan, S., Canziani, G.A., Famulari, A.L., Domínguez, R.O., Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging (1993) J. Neurol. Sci., 115, pp. 18-25
• Serra, J.A., Famulari, A.L., Kohan, S., Marschoff, E.R., Domínguez, R.O., De Lustig, E.S., Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives (1994) J. Neurol. Sci., 122, pp. 179-188
• Famulari, A.L., Marschoff, E.R., Serra, J.A., The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls (1996) J. Neurol. Sci., 141, pp. 69-78
• Serra, J.A., Domínguez, R.O., De Lustig, E.S., Guareschi, E.M., Famulari, A.L., Marschoff, E.R., Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients (2001) J. Neural. Transm., 108 (10), pp. 1135-1148
• Samiec, P.S., Drews-Botsch, C., Flagg, E.W., Glutathione in human plasma: Decline in association with aging, age-related macular degeneration, and diabetes (1998) Free Radic. Biol. Med., 24 (5), pp. 699-704
• Schmeichel, A.M., Schmelzer, J.D., Low, P.A., Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy (2003) Diabetes, 52 (1), pp. 165-171
• Hiramatsu, K., Arimori, S., Increased superoxide production by mononuclear cells of patients with hypertryglycerdemia and diabetes (1988) Diabetes, 37, pp. 832-837
• Baynes, J.W., Role of oxidative stress in development of complications in diabetes (1991) Diabetes, 40, pp. 405-412
• Seghrouchni, I., Drai, J., Bannier, E., Oxidative stress parameters in type I, type II and insulin-treated type II diabetes mellitus, insulin treatment efficiency (2002) Clin. Chim. Acta, 321 (12), pp. 89-96
• Lindstrom, J., Tuomilehto, J., The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk (2003) Diabetes Care, 26 (3), pp. 725-731
• Lee, F., Developmental aspects of experimental pulmonary oxygen toxicity (1991) Free Radic. Biol. Med., 11, pp. 463-494
• Birkeland, K.I., Kilhovd, B., Thorsby, P., Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile (2003) Diabet. Med., 20 (1), pp. 37-45
• Mc Khan, G., Drachman, D., Folstein, M., Katzman, R., Price, C., Stardlan, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease (1984) Neurology, 34, pp. 939-944
• Roman, G.C., Tatemichi, T.K., Erkinjuntti, T., Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop (1993) Neurology, 43, pp. 250-260
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000) Diabetes Care, 23, pp. 4-S19
• Psychiatric Association, A., Diagnostic and statistical manual of mental disorders (DSM IV) (1994) 4th Ed., , Washington: American Psychiatric Association
• Mattis, S., Mental status examination for organic mental syndrome in the elderly patient (1976) Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians, pp. 77-101. , L. Bellak, & T. Karasu. New York: Grune and Stratton
• Schwarb, S., Koberle, S., Spiegel, R., The Alzheimer's Disease Assessment Scale (ADAS): An instrument for early diagnosis of dementia? (1988) Int. J. Geriatr. Psychiatry, 3, pp. 45-53
• Hughes, C.P., Berg, L., Danziger, W.L., Coban, L.A., Martin, R.L., A new clinical scale for the staging of dementia (CDR) (1982) Br. J. Psychiatry, 140, pp. 566-572
• Hamilton, M.A., Rating scale for depression (1960) J. Neurol. Neurosurg. Psychiatry, 23, pp. 56-62
• Misra, H.P., Fridovich, I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase (1972) J. Biol. Chem., 247, pp. 3170-3175
• Jewett, S.L., Rocklin, A.M., Variation of one unit of activity with oxidation rate of organic substrate in indirect superoxide dismutase assays (1993) Anal. Biochem., 212 (2), pp. 555-559
• Lowry, O.H., Rosenbrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275
• Fraga, C.G., Leibovitz, B.E., Tappel, A.L.L., Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes (1988) Free Radic. Biol. Med., 4, pp. 155-161
• Lissi, E., Pascual, C., Del Castillo, M., Luminol luminescence induced by 2-2′ azo-bis (2 amidinopropane) thermolysis (1992) Free Radic. Res. Commun., 17, pp. 299-311
• Llesuy, S.F., Milei, J., González Flecha, B., Boveris, A., Myocardial damage induced by doxorubicins: Hydroperoxide-initiated chemiluminescence (1990) Free Radic. Biol. Med., 8, pp. 259-264
• González Flecha, B., Llesuy, S., Boveris, A., Hydroperoxide initiated chemiluminescence: An assay of oxidative in biopsies of heart and liver (1991) Free Radic. Biol. Med., 10, pp. 93-100
• Sokal, R.R., Rohlf, F.J., Biometry (1995) 3rd Ed., , New York: Freeman WH
• O'Brien, R.C., Ling, M., Balazs, N., Mercuri, J., In vitro and in vivo antioxidant properties of glicazide (2000) J. Diabetes Complications, 14, pp. 201-206
• Famulari, A.L., Serra, J.A., Marschoff, E.R., Heterogeneity in dementia of the Alzheimer type: Differing clinical and superoxide dismutase profiles are age related (1997) Neurology, 48 (3), pp. 165-A166
• Marschoff, E.R., Domínguez, R.O., De Lustig, E.S., Famulari, A.L., Serra, J.A., Neurological deterioration, heterogeneity of Alzheimer disease and antioxidant profiles: A four trials meta-analysis (1997) J. Neurol. Sci., 150, p. 22
• Famulari, A.L., Bartolomé, E.L., Serra, J.A., Heterogeneity in dementia of Alzheimer type: Differing clinical onset and evolution is age related (1997) J. Neurol. Sci., 150, p. 20
• Gumieniczek, A., Hopkaa, H., Wójtowicz, Z., Nieradko, M., Differences in antioxidant status in skeletal muscle tissue in experimental diabetes (2001) Clin. Chim. Acta, 314 (12), pp. 39-45
• Giugliano, D., Ceriello, A., Paolisso, G., Diabetes mellitus, hypertension, and cardiovascular disease: Which role for oxidative stress? (1995) Metabolism, 44 (3), pp. 363-368
• Tessier, D., Khalil, A., Fulop, T., Effects of an oral glucose challenge on free radicals/antioxidants balance in an older population with type II diabetes (1999) J. Gerontol. a Biol. Sci. Med. Sci., 54 (11), pp. 541-M545
• Hunt, J.V., Gean, R., Wolff, S., Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging (1988) Biochem. J., 256, pp. 205-212
• Robertson, R.P., Harmon, J., Tran, P.O., Tanaka, Y., Takahashi, H., Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection (2003) Diabetes, 52 (3), pp. 581-587
• Esteghamati, A., Zarban, A., Doosti, M., Evaluation of antioxidant status and oxidative stress markers in type II diabetes mellitus (2002) Int. J. Endocrinol. Metab., 3 (4). , (Ser.Numb.12)
• Warner, H.R., Superoxide dismutase, aging, and degenerative disease (1994) Free Radic. Biol. Med., 17 (3), pp. 249-258
• Volicer, L., Crin, P.B., Involvement of free radicals in dementia of the Alzheimer's type: A hypothesis (1990) Neurobiol. Aging, 11, pp. 567-571
• Munch, G., Deuther-Conrad, W., Gasic-Milenkovic, J., Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease - A target for neuroprotective treatment strategies? (2002) J. Neural. Transm., 62, pp. 303-307

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------